Planned sale of 9,672 AEHR common shares disclosed

A holder of AEHR common stock filed a notice of intent to sell shares.

Rhea-AI Filing Summary

A holder of AEHR common stock filed a notice of intent to sell shares. The planned transaction covers 9,672 shares of common stock to be sold through Fidelity Brokerage Services LLC on August 13, 2026 on NASDAQ, with an aggregate market value of $1,235,287.65. The shares to be sold were originally acquired in several transactions, including 7,200 shares obtained in a merger for cash on August 1, 2024, and restricted stock that vested as compensation in lots of 2,091 shares on July 2, 2025 and 381 shares on August 1, 2025.

Key Figures

Shares planned for sale: 9,672 shares Aggregate market value: $1,235,287.65 Merger-acquired shares: 7,200 shares +3 more

6 metrics

Shares planned for sale 9,672 shares Common stock to be sold through Fidelity on NASDAQ

Aggregate market value $1,235,287.65 Value of 9,672 AEHR common shares planned for sale

Merger-acquired shares 7,200 shares Common stock acquired in a merger on August 1, 2024

Restricted stock vesting 2025-07-02 2,091 shares Common stock vested as compensation on July 2, 2025

Restricted stock vesting 2025-08-01 381 shares Common stock vested as compensation on August 1, 2025

Proposed sale date August 13, 2026 Planned execution date for sale of 9,672 shares

Key Terms

Merger, Restricted Stock Vesting, Compensation

3 terms

Merger financial

"Common | 08/01/2024 | Merger | Issuer"

A merger is when two companies combine into a single business, with ownership and control reorganized so they operate as one entity. For investors it matters because mergers can change the value and risk of holdings—shares may be exchanged, diluted, or rise if the combined company saves costs or gains market power, and the deal often depends on regulatory approval and successful integration like two households joining resources and routines.

Restricted Stock Vesting financial

"Common | 07/02/2025 | Restricted Stock Vesting | Issuer"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

Compensation financial

"381 | 08/01/2025 | Compensation"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stock sale is being planned for AEHR in this Form 144 filing?

The filing discloses a planned sale of 9,672 AEHR common shares through Fidelity Brokerage Services LLC on August 13, 2026 on NASDAQ, with an aggregate market value of $1,235,287.65.

What is the aggregate market value of AEHR shares covered by this Form 144?

The notice covers AEHR common stock with an aggregate market value of $1,235,287.65. This amount relates to the planned sale of 9,672 shares of common stock to be executed on NASDAQ through Fidelity Brokerage Services LLC.

When were the AEHR shares in this Form 144 originally acquired?

The shares were acquired in several transactions: 7,200 shares via a merger on August 1, 2024, plus restricted stock vesting events of 2,091 shares on July 2, 2025 and 381 shares on August 1, 2025, all from the issuer.

How many AEHR shares from a merger are included in the planned sale?

The planned sale includes 7,200 AEHR common shares that were originally acquired in connection with a merger on August 1, 2024. The consideration for this merger-related acquisition was listed as cash from the issuer.

What portion of the AEHR shares in this Form 144 came from restricted stock vesting?

Restricted stock vesting contributed 2,472 AEHR shares in total, consisting of 2,091 shares vesting on July 2, 2025 and 381 shares vesting on August 1, 2025, each described as compensation from the issuer.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/13/2026 - 04:12 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002043583
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	AEHR TEST SYSTEMS
SEC File Number	000-22893
Address of Issuer	400 KATO TERRACE FREMONT CALIFORNIA 94539
Phone	5106239400
Name of Person for Whose Account the Securities are To Be Sold	SALAMONE ALBERTO
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	9672	1235287.65	32620450	08/13/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/01/2024	Merger	Issuer			7200	08/01/2024	Cash
Common	07/02/2025	Restricted Stock Vesting	Issuer			2091	07/02/2025	Compensation
Common	08/01/2025	Restricted Stock Vesting	Issuer			381	08/01/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/13/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Daniel Tucci, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Alberto Salamone
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)